The HerediGene: Children’s Study is the world’s largest DNA mapping effort, https://intermountainhealthcare.org/heredigene, to be undertaken in children. The study aims to help children access future treatments and possible cures for genetic disorders, based on their unique DNA.
The Study will involve the voluntary collection of 50,000 DNA samples of children as young as newborns, as well as their parents and siblings who wish to participate at the Intermountain Primary Children’s Hospital https://intermountainhealthcare.org/primary-childrens. The goal and wish is to discover new connections between genetics and human disease.
Information from the study will help researchers at the Center for Personalized Medicine, a collaboration between Primary Children’s Hospital, Intermountain Precision Genomics and pediatric specialists and researchers at University of Utah Health better understand genetics and research new ways to treat genetic diseases.
“The HerediGene Children’s Study will transform our ability to diagnose and even prevent future diseases in children and families representing the most compassionate application of precision medicine today,”, said Lincoln Nadauld, MD, PhD, Oncologist and Vice President and Chief of Precision Health and Academics at Intermountain Healthcare.